Tevogen Bio Holdings Inc. - Common Stock, par value $0.0001 per share (TVGN) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2024 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
TVGN on Nasdaq
Shares outstanding
200,852,220
Price per share
$0.30
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
5,074,358
Total reported value
$1,680,273
% of total 13F portfolios
0%
Share change
+254,760
Value change
+$30,909
Number of holders
47
Price from insider filings
$0.30
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Tevogen Bio Holdings Inc. - Common Stock, par value $0.0001 per share (TVGN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Saadi Ryan H. 62% -3.8% $54,792,486 -$211,200 124,528,376 -0.38% Ryan H. Saadi 11 Dec 2025

As of 31 Dec 2025, 47 institutional investors reported holding 5,074,358 shares of Tevogen Bio Holdings Inc. - Common Stock, par value $0.0001 per share (TVGN). This represents 2.5% of the company’s total 200,852,220 outstanding shares.

Institutional Holders of Tevogen Bio Holdings Inc. - Common Stock, par value $0.0001 per share (TVGN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 5,074,358 $1,680,273 +$30,909 $0.33 47
2025 Q3 4,815,177 $3,781,892 -$59,467 $0.79 51
2025 Q2 4,835,189 $6,044,298 +$1,234,919 $1.25 55
2025 Q1 3,851,004 $4,160,133 +$1,460,233 $1.08 49
2024 Q4 2,414,123 $2,488,565 -$513,223 $1.03 42
2024 Q3 5,647,671 $2,081,020 +$96,992 $0.37 33
2024 Q2 3,698,099 $2,674,095 -$2,032,470 $0.72 26
2024 Q1 6,779,132 $30,688,068 +$30,688,068 $3.75 5